The DEA Claims That Synthetic THC Is Safer Than the Natural Stuff in Regular Marijuana

Syndros, a liquid marijuana substitute that contains a synthetic version of the marijuana ingredient that makes users feel high (THC), has been assigned a less restrictive drug category than real weed.

The liquid is developed by Arizona-based pharmaceutical company InSys Therapeutics, the company behind synthetic opioid Fentanyl, which is around 100 times more powerful than morphine.

Syndros was previously granted approval from the Food and Drug Administration (FDA), and received a Schedule II classification from the Drug Enforcement Administration (DEA) as of March 23. For those keeping track at home, regular marijuana currently holds the same Schedule I classification as heroin — meaning that it has a “high potential for abuse” and “no accepted medical use.”

Despite pleas, the DEA has rejected two attempts to reclassify marijuana over the past year, although the agency seemingly had no problem giving Syndros the lower-grade Schedule II categorization — meaning that...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: